Tiapride hydrochloride

CAS No. 51012-33-0

Tiapride hydrochloride( —— )

Catalog No. M14753 CAS No. 51012-33-0

Tiapride is a drug that selectively blocks D2 and D3 dopamine receptors in the brain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 32 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tiapride hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Tiapride is a drug that selectively blocks D2 and D3 dopamine receptors in the brain.
  • Description
    Tiapride is a drug that selectively blocks D2 and D3 dopamine receptors in the brain. It is used to treat a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    D2| D3
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    51012-33-0
  • Formula Weight
    364.89
  • Molecular Formula
    C15H24N2O4S·HCl
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 10 mM
  • SMILES
    Cl.CCN(CC)CCNC(=O)C1=C(OC)C=CC(=C1)S(C)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Scatton B, et al. Eur Psychiatry. 2001 Jan;16 Suppl 1:29s-34s.
molnova catalog
related products
  • Bromocriptine mesyla...

    Bromocriptine (CB-154) is a dopamine D2 receptor agonist (Ki=3 nM) and and various serotonin receptors, also inhibits the release of glutamate by reversing the glutamate GLT1 transporter.

  • Cabergoline

    Cabergoline is an ergot derived-dopamine D2-like receptor agonist. It has high affinity for D2, D3, and 5-HT2B receptors (Ki=0.7, 1.5, and 1.2, respectively).Cabergoline permits rapid and effective hormonal and tumor control by normalizing prolactin-producing pituitary adenomas levels.Cabergoline acts as a potent agonist of D2, D3 and 5-HT2B receptors.

  • PF-00217830

    PF-00217830 is a serotonin 1A receptor agonist, dopamine D2 receptor agonist, and serotonin 2A receptor antagonist.PF-00217830 may be used in the study of schizophrenia.